Sample | Title | Value | Rank |
GSM52504 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 1) | 16.1 | 37 |
GSM52508 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2(sample 2) | 9.7 | 27 |
GSM52518 | SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 1) | 65.5 | 61 |
GSM52519 | SK-MEL-2 cells treated with Ad-LacZ at MOI 2 plus doxorubicin (sample 2) | 49.7 | 56 |
GSM52516 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 1) | 32.3 | 49 |
GSM52517 | SK-MEL-2 cells treated with Ad-E2F-1 at MOI 2 plus doxorubicin (sample 2) | 35.3 | 51 |